GENELUX Corp ($GNLX)
Yu Yong โ SVP, Clinical Development
Shares
906
Price
$2.42
Total Value
$2,192.52
Nearby Earnings
Mar 19, 2026
EPS:-0.24 (est: -0.22)+9.9%
Revenue:$8.00K
Mar 27, 2026
EPS:Est: -0.22
Apr 6, 2026
EPS:Est: -0.22
Transaction Details
| Insider | Yu Yong |
|---|---|
| Title | SVP, Clinical Development |
| Transaction Date | Mar 24, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 26, 2026 |
| Shares Sold | 906 |
| Price per Share | $2.42 |
| Total Value | $2,192.52 |
| Shares Owned After | 144,938 |
| Derivative | No |
| Accession Number | 0001493152-26-012970 |
| Document | View SEC Filing |